4.5 Article

Effects of iRoot SP on osteogenic differentiation of human stem cells from apical papilla

Journal

BMC ORAL HEALTH
Volume 21, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12903-021-01769-9

Keywords

Nano-bioceramics; iRoot SP; Human stem cells from apical papilla; Osteogenic differentiation

Funding

  1. Young Scientists Fund of the National Natural Science Foundation of China [81500847]

Ask authors/readers for more resources

The study evaluated the effects of iRoot SP on proliferation and osteogenic differentiation in human stem cells from the apical papilla. Results showed that iRoot SP is non-toxic at low concentrations, increases cell migration capacity, promotes osteogenic activity and formation of mineralized nodules, and upregulates the expression of osteogenic markers. Overall, iRoot SP is effective for periapical bone regeneration.
Background Research shows that nano-bioceramics can modulate the differentiation of dental stem cells. The novel ready-to-use calcium-silicate-based root-canal sealer iRoot SP is widely used in root filling. Accordingly, the aim of this study was to evaluate the effects of iRoot SP on proliferation and osteogenic differentiation in human stem cells from the apical papilla (hSCAPs). Methods hSCAPs were isolated and characterized in vitro, then cultured with various concentrations of iRoot SP extract. Cell proliferation was assessed by CCK-8 assay, and scratch-wound-healing assays were performed to evaluate cell-migration capacity. hSCAPs were then cultured in osteogenic medium supplemented with iRoot SP extracts. Alkaline phosphatase (ALP) activity assay was used to evaluate ALP enzyme levels. Alizarin red staining and cetylpyridinium chloride (CPC) assays were performed to assess calcified-nodule formation and matrix-calcium accumulation of hSCAPs. The mRNA and protein expression levels of the osteogenic markers OCN, OSX, Runx2, and DSPP were determined by qRT-PCR and Western blotting. The data were analyzed using one-way ANOVA and LSD-t tests. Results iRoot SP at low concentrations (2, 0.2, and 0.02 mg/mL) is nontoxic to hSCAPs. iRoot SP at concentrations of 0.02 and 0.2 mg/mL significantly increases cell-migration capacity. In terms of osteogenic differentiation, 0.2 mg/mL iRoot SP promotes intracellular ALP activity and the formation of mineralized nodules. Moreover, the expression of osteogenic markers at the mRNA and protein levels are upregulated by iRoot SP. Conclusion iRoot SP is an effective filling material for periapical bone regeneration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available